Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Lin, Chun Mao ^a,b   Fang, Chia Lang ^a,c   Hseu, You Cheng ^d,e   Chen, Chun Liang ^f   Wang, Jin Wun ^f   Hsu, Sheng Lung ^f   Tu, Ming Dao ^f   Hung, Shih Ting ^g   Tai, Chein ^h   Uen, Yih Huei ^f,g,h   Lin, Kai Yuan ^g,i  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f Chi Mei Hospital Chiali   (Taiwan)

^g CHI MEI MEDICAL CENTER   (Taiwan)

^h SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

ⁱ CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX4; SOX4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLON RESECTION; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN EXPRESSION; TUMOR LOCALIZATION; CELL LINE; CELL NUCLEUS; COLON TUMOR; FOLLOW UP; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CELL LINE; CELL NUCLEUS; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SOXC TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84879548023     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067128     Document Type: Article

References (33)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR, et al. (2005) Colorectal cancer. Lancet 365: 153-165.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Goel A, Boland CR, (2010) Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol 26: 47-52.
4. Ashktorab H, Schäffer AA, Daremipouran M, Smoot DT, Lee E, et al. (2010) Distinct genetic alterations in colorectal cancer. PLoS ONE 5: e8879.
5. Lin KY, Tai C, Hsu JC, Li CF, Fang CL, et al. (2011) Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer. PLoS ONE 6: e17193.
6. Kwon KA, Kim SH, Oh SY, Lee S, Han JY, et al. (2010) Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10: 203.
7. Wang CG, Ye YJ, Yuan J, Liu FF, Zhang H, et al. (2010) EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol 16: 2421-2427.
8. Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, et al. (2010) TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer. Ann Surg Oncol 17: 967-972.
9. Schepers GE, Teasdale RD, Koopman P, (2002) Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 3: 167-170.
10. Wilson M, Koopman P, (2002) Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12: 441-446.
11. van de Wetering M, Oosterwegel M, van Norren K, Clevers H, (1993) Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J 12: 3847-3854.
12. Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H, et al. (1998) Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res 83: 986-994.
13. Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, et al. (1996) Defects in cardiac outflow tract formation and pro-Blymphocyte expansion in mice lacking Sox-4. Nature 380: 711-714.
14. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, et al. (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32: 166-174.
15. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, et al. (2002) Genomewide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 32: 160-165.
16. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, et al. (2004) High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res 64: 4419-4427.
17. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, et al. (2006) SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Research 66: 3434-3442.
18. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, et al. (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Research 66: 4011-4019.
19. Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, et al. (2009) The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Human Molecular Genetics 18: 1343-1352.
20. Pramoonjago P, Baras AS, Moskaluk CA, (2006) Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene 25: 5626-5639.
21. Pan X, Zhao J, Zhang WN, Li HY, Mu R, et al. (2009) Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proceedings of the National Academy of Sciences of the United States of America 106: 3788-3793.
22. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-233.
23. de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, et al. (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro-Oncology 10: 648-660.
24. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, et al. (2009) Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrail cancer. Cancer Res 69: 9038-9046.
25. Hur W, Rhim H, Jung CK, Kim JD, Bae SH, et al. (2010) SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro. Carcinogenesis 31: 1298-1307.
26. Jafarnejad SM, Wani AA, Mertinka M, Li G, (2010) Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol 177: 32741-32752.
27. Wang C, Zhao H, Lu J, Yin J, Zang L, et al. (2012) Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma. Diagn Pathol 7: 41.
28. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
29. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumor invasion and metastasis. Nat Cell Biol 10: 202-210.
30. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, et al. (2007) Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 67: 11254-11262.
31. Guarino M, (2007) Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39: 2153-2160.
32. Voulgari A, Pintzas A, (2009) Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 5-90.
33. Zhang J, Liang Q, Lei Y, Yao M, Li L, et al. (2012) SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res 72: 4597-4608.